CD8A and nonpapillary renal cell carcinoma: The TMB, neoantigen load and immune checkpoint gene expression might not be significantly associated with ICB therapeutic efficacy for ccRCC (10, 49), but were closely associated with CD8+T cells (27, 50, 51).